ACIR joins NET-PHARMA HUB to strengthen exports to Central Asia

ACIR Southern Europe has officially joined the NET-PHARMA HUB, strengthening a strategic alliance as part of its project to export pharmaceutical technologies, medicines, and biotech solutions to the countries of Eurasia and Central Asia.

This partnership reinforces ACIR’s commitment to fostering international trade and investment projects in the pharmaceutical sector, opening new channels for cooperation between innovative European companies and emerging markets with strong demand for healthcare solutions.

Through this HUB, ACIR and its partners will:

• Identify European companies interested in entering Central Asian markets.

• Organize technical and business visits with potential distributors in Uzbekistan, Kazakhstan, and other countries.

• Facilitate technology transfer agreements with local producers.

• Provide support on certification and international regulatory compliance.

Thanks to NET-PHARMA’s infrastructure and reputation as a key European pharmaceutical cluster, this collaboration enables a more dynamic and results-driven engagement.

ACIR Southern Europe’s experts, together with their local partners in Central Asia, are ready to support companies looking to take part in this initiative, whether through export, production agreements, or joint ventures.